Status:
UNKNOWN
The Emotional Impact of Surveillance for Pancreatic Cancer
Lead Sponsor:
Azienda Ospedaliera Universitaria Integrata Verona
Conditions:
Pancreatic Cancer
Psychological Distress
Eligibility:
All Genders
Phase:
NA
Brief Summary
Due to its rarity a population screening program for pancreatic cancer is not possible. For this reason, considering background data on genetic predisposition and familiarity for this lethal tumor, ef...
Eligibility Criteria
Inclusion
- Being enrolled in the Institutional surveillance program for pancreatic cancer
- Ability to understand the details and implications of a study protocol.
Exclusion
- None
Key Trial Info
Start Date :
July 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04024345
Start Date
July 1 2017
End Date
December 31 2021
Last Update
March 31 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Verona
Verona, VR, Italy, 37134